Abstract: Predictors of adherence to treatment in women with fibromyalgia

1 Star2 Stars3 Stars4 Stars5 Stars (311 votes, average: 2.90 out of 5)
Loading...

Clin J Pain. 2006 Mar-Apr;22(3):286-94.

Dobkin PL, Sita A, Sewitch MJ.

Department of Medicine, McGill University, Montreal, Quebec, Canada. patricia.dobkin@mcgill.ca

OBJECTIVES: The goal of this study was to identify predictors of general and medication adherence in women with fibromyalgia (FM).

METHODS: Participants were 142 women recruited from tertiary care hospitals or the community and 10 rheumatologists. Participants’ demographic, clinical, and psychosocial characteristics, as well as patient-physician discordance, were assessed at the index visit. Adherence was assessed 6 months later. Multivariable generalized estimating equations were used to identify predictors of general adherence and adherence to medication.

RESULTS: The average age of participants was 50.9 years (SD=10.2) and the median duration of FM was 32 months. Participants reported extensive use of health services and medications. The mean score for general adherence was 61.0 (SD=22.4; range 0-100) and 52.9% of the cohort reported at least one form of behavior reflecting nonadherence to medications.

More general adherence was significantly predicted by lower patient-physician discordance on patient well-being and lower patient psychological distress. Medication adherence was significantly predicted by higher affective pain and lower patient psychological distress.

CONCLUSIONS: Adherence is influenced by both clinical (patient-physician discordance and pain) and psychological (distress) factors in women with FM. Improvements in these domains may improve adherence in FM.

PMID: 16514330 [PubMed – in process]

1 Star2 Stars3 Stars4 Stars5 Stars (311 votes, average: 2.90 out of 5)
Loading...



Leave a Reply